Competition and profitability of pharmaceuticals in Asia

Competition in the pharmaceutical industry in Asia

The changing landscape of Asian economies is modifying the dynamics of competition and profitability between corporations. In this report from the Economist Intelligence Unit, several demographic, legal and financial trends are analyzed to search for market insights as well as best practices for corporate finance and strategy in Asia.

For a more comfortable reading, it is quite suggested to open the report in full screen!

View / download the report as a .pdf document.

Summary – Asia Competition barometer: Pharmaceuticals

Preface – page 2

Executive summary – page 3

Asia’s growing importance for corporate performance and global competitiveness – page 5

Competition and profitability at Asian firms – page 9

  • Competition: Marginal decrease in an extremely fragmented sector – page 9
  • Profitability: Slow growth – page 11
  • Case study: Glenmark Pharmaceuticals – page 13

Positioning for success in Asia – page 14

  • Sustained growth – page 14
  • Patent expirations will lead to more partnerships involving Asian generics manufacturers – page 15
  • Case Study: AstraZeneca – page 17
  • Case Study: Lonza – page 18

Outlook – page 19

Barometer methodology – page 21

Report from March 2012 by the Economist Group

Leave a Reply

Your email address will not be published.